|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 20, 2018 ) The global Capecitabine market is anticipated to grow at XX% CAGR from 2017 to 2022 and it is estimated that the global market was valued at USD XX billion in 2017 and is expected to reach USD XX billion by 2022.
View Full Report @ https://www.marketdataforecast.com/market-reports/capecitabine-market-6413/
Capecitabine is a chemotherapy drug used in the treatment of cancers such as gastric cancer, colorectal cancer, and breast cancer. It acts on the cancer cells and not only does it prevents them from further multiplying, buts also helps in destroying the cancer cells.
Request Sample @ https://www.marketdataforecast.com/market-reports/capecitabine-market-6413/request-sample
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of capecitabine drive the growth of the capecitabine market. According to the National Cancer Institute around 135,430 people are estimated to suffer from colon and rectum cancer and 50,260 people died of colon and rectum cancer in 2017 in the U.S. Furthermore, rise in healthcare expenditure and increase in investment in cancer treatment or assisted programs by governments and private organizations such as Cancer Care and Cancer Suraksha Scheme are anticipated to boost the market growth. However, high cost of capecitabine, adverse effects, presence of substitutes, such as raltitrexed and leucovorin, and stringent government regulations related to the safety and efficacy of capecitabine hinder the market growth. Ongoing R&D activities related to capecitabine are anticipated to present new opportunities for the market.
Inquire Before Buy @ https://www.marketdataforecast.com/market-reports/capecitabine-market-6413/inquire
Market Segmentation
• Application
• Introduction
• Colon Cancer
• Rectal Cancer
• Breast Cancer
• Gastric Cancer
• Others
• Y-o-Y Growth Analysis, By Application
• Market Attractiveness Analysis, By Application
• Market Share Analysis, By Application
Drug Formulation
• Introduction
• Tablets
• Capsules
• Y-o-Y Growth Analysis, By Drug Formulation
• Market Attractiveness Analysis, By Drug Formulation
• Market Share Analysis, By Drug Formulation
On the basis of geography, the Capecitabine market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America accounted for the largest share of the Capecitabine market followed by Europe and Asia Pacific. Asia Pacific is expected to witness the highest CAGR in the coming years.
Buy Now @ https://www.marketdataforecast.com/cart/buy-now/capecitabine-market-6413/
The market is dominated by companies like Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Perrigo Company plc, Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation and Avita Medical Limited.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast.
Abhishek Shukla
1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
